chronic obstructive pulmonary disease management

shaikiso 9 views 11 slides May 05, 2024
Slide 1
Slide 1 of 11
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11

About This Presentation

copd definition, groups and relevant management


Slide Content

COPD

Introduction COPD is a progressive respiratory condition characterized by persistent airflow limitation, primarily caused by exposure to harmful particles or gases, such as tobacco smoke. It encompasses two main conditions: chronic bronchitis and emphysema. COPD is the fourth leading cause of death and affects >10 million persons in the United States , about 250 million individuals with COPD worldwide.

Pathophysiology Exposure to harmful gases, triggers an inflammatory response in the airways, leading to tissue damage and narrowing of the air passages. Chronic bronchitis a clinically defined condition that involves inflammation of the bronchial tubes, leading to excessive phlegm production and cough. Emphysema an anatomically defined condition that involves destruction of the alveoli with air space enlargement, resulting in decreased lung elasticity and airflow limitation.

Pathogenesis of emphysema α1 Antitrypsin Deficiency

Diagnosis Diagnosis typically involves pulmonary function tests, including spirometry, to assess lung function and severity of airflow limitation. Additional tests such as chest X-rays or CT scans may be utilized to assess lung structure and rule out other conditions. Diagnosis is confirmed when a patient exhibits a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio less than 0.70.

Gold criteria

Treatment Approaches Pharmacological interventions include bronchodilators (beta-agonists, anticholinergics), corticosteroids (oral/inhaled), PDE-4 inhibitors and Azithromycin to alleviate symptoms and reduce exacerbation risk. Non-pharmacological interventions such as smoking cessation, pulmonary rehabilitation, oxygen therapy and vaccination against influenza and pneumococcus are crucial components of COPD management. Surgical options like LVRS (lung volume reduction surgery) or lung transplantation may be considered in severe cases.

Severity assessment

A few word on exacerbation Defined by worsening of the respiratory symptoms- dyspnea, cough, weezing and char a cter of suptum More then 50% of exacerbations caused due to bacterial or viral infections A comprehensive assesment of change in respiratory symptoms and worsening of dyspnea. A lso fever, nausea, vomiting, diarrhea, myalgia and chills.

Initail Treatment

F ollow up treatment